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ABSTRACT
Embolization is a remarkably versatile procedure used in nearly all vascular and
nonvascular systems to treat a wide range of pathology. The published literature is rich with
studies demonstrating the enormous therapeutic potential offered by embolization proce-
dures, and the possibilities continue to expand with the advent of new embolization agents
and techniques. Unfortunately, with this variety and innovation comes a wide spectrum of
potential complications, not always easy to classify and summarize, associated with
embolization. This article reviews the procedures and associated complications of arterial
and venous embolization procedures, organized by vascular distribution.
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Embolization can be defined as any endoluminal
procedure, vascular or nonvascular, to occlude a vessel to
obtain therapeutic benefit. The first embolizations date
from the 1960s and 1970s, and articles by Baum, Dotter,
Ro¨sch and Tadavarthy belong to the history of medi-
cine.1 Many series demonstrate the enormous therapeu-
tic potential offered by the various procedures that
belong under the heading of embolizations. A wide
variety of materials and techniques have been used, and
new possibilities and fields have opened up regarding the
therapeutic benefits of occluding a vessel. Because these
techniques result in a variety of possible complications, it
is not easy to classify, summarize, or explain the reason
for each of the possible complications of embolization.
What follows is a description of the complications that
can arise when different vascular areas are embolized.
HEAD AND NECK
Embolization procedures for extracranial disease in the
head and neck region are mostly performed for intract-
able epistaxis or in the presence of a hypervascular tumor
either prior to surgical removal or as a palliative treat-
ment. Since the first treatment performed by Sokoloff
et al in 1974,2 arterial embolization is nowadays widely
recommended as the method of choice for the treatment
of posterior intractable epistaxis. The majority of cases
(70%) are idiopathic, but epistaxis can occur secondary to
trauma, tumor, radiotherapy, coagulopathy, or vascular
malformations or diseases such as Osler-Webber-
Rendu. As a result, follow-up radiological and endo-
scopic evaluations are essential to avoid misdiagnosis.3
The source of bleeding is usually the septal branch
and less commonly the posterolateral branch of the
sphenopalatine artery, which arise from the distal inter-
nal maxillary artery. There is also rich collateral supply
from the ophthalmic artery via the anterior and posterior
ethmoidal arteries, the descending palatine artery, and
the facial artery via the superior labial artery.4 Nowadays,
with the development of new materials, it is possible to
selectively catheterize and embolize these branches with
the aid of a microcatheter.
The embolic materials most commonly employed
are particles, either of gelatin sponge or polyvinyl alcohol
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(PVA), and more recently trys-acril gelatin micro-
spheres.5,6 The use of coils is not recommended because
proximal occlusion may not only induce the development
of collateral circulation but also close the door to repeat
access in case of recurrence. The cure rate achieved in
most reported series is 80% or higher, particularly when
the ipsilateral facial artery and contralateral sphenopala-
tine artery are simultaneously embolized.7–12 Some have
even used a mixture of hystoacril with Lipiodol (Guerbet,
Paris, France).13
The reported complication rates are very varia-
ble. Minor complication rates range between 2.2 and
25%,7–9,11,12,14 although Oguni et al have reported a rate
of 45%, attributing this to the difference in definition of
minor complication.15 Serious complication rates vary
between 0 and 6% when looking at large series.7,9,14
Generally considered minor, the most common
complication encountered is headache or temporofacial
pain, more common in cases where two or more arteries
are embolized with gelatin sponge.15 In fact, Siniluoto
et al reported that 96.8% of their patients experienced
mild to moderate pain in the temporal area during the
first 24 hours after embolization.16
Soft tissue necrosis has also been described as a
complication, particularly when more than one vessel is
occluded (contralateral sphenopalatine artery or facial
artery) or when liquid embolic agents are used.10,15
Small particles tend to produce a more distal occlusion
and may also result in local ischemia and even nasal
septal perforation.17 At times, it is difficult to discern if
the necrosis is secondary to the embolization procedure
or to prolonged packing. Ischemic injury may not only
affect the mucosa but also the cranial nerves, possibly
resulting in temporary or permanent cranial nerve
palsy.18,19 Depending on the cranial nerve affected, the
presenting symptoms will be very variable, including
diplopia, dysphagia, and numbness.
The most feared complications, however, are those
in connection with the passage of embolic material into
the intracranial arteries, which may result in stroke9 or
blindness.20Thismay occur due to reflux from the external
carotid artery into the internal carotid artery or through
passage of embolic material through extracranial-intra-
cranial anastomoses. At times, it may become necessary to
perform selective embolization of branches originating
from the ophthalmic artery. In this situation, the micro-
catheter should be advanced beyond the second portion
of the ophthalmic artery to prevent embolic material
from entering the central artery of the retina21 (Fig. 1).
In the presence of ipsilateral internal carotid
artery stenosis or occlusion, the use of particles may be
particularly dangerous due to the development of exter-
nal carotid to internal carotid anastomoses. In this
situation, endovascular therapy may still be safely and
effectively performed with coils in the pterygopalatine
segment of the internal maxillary artery.22
PULMONARY AND BRONCHIAL ARTERIES
Pulmonary arteriovenous malformations (PAVMs) con-
sist of abnormal direct communications between the
pulmonary artery and the pulmonary vein. Most com-
monly they are congenital, and often they are associated
with hereditary hemorrhagic telangiectasia, also known as
Rendu-Osler-Weber disease. The hemodynamic result is
a right-to-left shunt, which may cause paradoxical em-
bolism and systemic infection. Hemothorax and hemopt-
ysis are also potential complications.23–25 Traditionally,
surgery was the only curative treatment available, but
nowadays transcatheter embolization (TCE) is widely
accepted as the procedure of choice26,27 since the first
report by Porstmann in 1977.28 The overall rate of
complications during TCE is estimated to range between
10 and 15% when performed by experienced hands, with
no reported mortality.29–31 Given the low complication
rate of TCE and its efficacy with a success rate approach-
ing 99%, the indication for treating a PAVM is estab-
lished in the presence of related symptoms or when the
feeding vessels are 3 mm in diameter or larger.29,32,33
The most commonly used devices for closing
PAVMs are detachable balloons and coils. Whatever
device is chosen, the aim of the procedure is to perma-
nently occlude the abnormal communication, preserving
the blood flow in any proximal vessel supplying normal
lung parenchyma. Ideally, the catheter tip should be
placed as close to the neck of the PAVM as possible or
even on the venous sac when there is a short arterial
feeder.34,35 An occlusion that is very proximal may result
in early recanalization by collateral perfusion from bron-
chial arteries or lung infarction, although due to the dual
blood supply to the lung, the latter will only occur when
the bronchial arteries are also occluded.36 On the other
hand, if the closing device is too small, the coil or balloon
may migrate into the systemic circulation. Traditionally,
balloons had the advantage over coils in that they could
be retrieved before detachment if they were found to be
of incorrect size or improperly positioned. Nowadays,
with the introduction of detachable coils, this is no
longer an issue.23,32,36
Systemic migration of the embolic device, which
has been reported to occur in up to 3% of cases, is
probably the most feared complication as it may result in
stroke.30,33,38 Retrieval of a migrated coil might be
possible with devices such as a gooseneck snare. When
a balloon migrates, attempts can be made to deflate it by
puncturing it with a needle inserted percutaneously,
depending on its location.39
Pleuritic chest pain is the most commonly re-
ported complication following TCE.29,30,36 It usually
appears within the first 48 hours and responds well to
analgesics. The incidence of this complication appears to
be related to the size of the PAVM, being present in up
to 31% of patients in whom the occluded PAVM has
feeding vessels larger than 8 mm in diameter.33 Delayed
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pleurisy (4 to 6 weeks after TCE) in association with
high fever has also been reported to occur, particularly
following coil embolization.32
It has been reported that 2% of patients might
experience air embolism during the procedure, which
clinically manifests as angina and bradycardia.27,29 A
further possible complication is the development or
aggravation of preexisting pulmonary hypertension pre-
sumably in connection with the closure of the PAVM
that acts as a low-resistance vascular circuit.37,38,40
To minimize the chances of balloons deflating
spontaneously, it is important that they are filled with
contrast isotonic to blood. In this respect, silicone
balloons remain inflated during a longer period than
latex balloons although both are equally effective in
occluding the PAVM.41 Tight coil packing is also
advised to prevent recanalization. In a recently published
study there was no statistically significant difference
between platinum and stainless steel coils in terms of
achieving a successful sustained occlusion.31
Bronchial artery embolization (BAE) is a well-
established procedure in the management of massive and
recurrent hemoptysis.42–47 Embolization in this territory
is most commonly performed with particles such as PVA
Figure 1 (A–D) Patient with massive epistaxis who has had three embolizations of the internal maxillary artery branches on both sides.
The arteriography of the internal carotid artery shows the presence of a thick infraorbital artery that reaches the nostril and depends on
the ophthalmic artery. After the catheterization of the ophthalmic artery, a microcatheter is inserted distally to the origin of the retinal
branches; 150 to 300 microparticles were used. During the embolization a retrograde opacification of the whole ophthalmic artery was
observed. An arteriography was performed from the internal carotid artery, which showed complete occlusion of the ophthalmic artery.
The patient lost the vision in his left eye. There were no further episodes of epistaxis.
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or more recently tris-acryl gelatin microspheres.48,49 The
use of thrombin as an embolic agent has also been
recently described.50 A thorough knowledge of normal
and variant bronchial arterial anatomy as well as collat-
eral supply is necessary prior to embarking on any
embolization procedure.51,52 The most dreaded and
serious complication of this procedure is spinal cord
ischemia secondary to inadvertent embolization of the
anterior or posterior spinal arteries via radiculomedul-
lary arteries, which may arise from the bronchial arteries.
This complication has been described to occur in
1.4 to 6.5% of BAE according to different published
series.44,53,54 The use of a microcatheter may be indi-
cated in this situation so that BAE may be performed
from a more distal position.55
One must also be aware of the presence of any
bronchopulmonary anastomoses to either the pulmonary
arteries or veins. It has been experimentally demon-
strated that these anastomoses measure just over
300 mm,56 and because of this it is recommended that
any particle employed as embolic agent should be larger
than this.57 We had in fact one case in which passage of
embolic trys-acril gelatin microspheres through tumoral
bronchopulmonary anastomoses resulted in cerebral em-
bolization, which fortunately resolved, leaving no seque-
lae. Furthermore, the use of smaller particles will also
result in a overly distal occlusion that may impede the
normal blood supply to other anatomical structures, such
as the esophagus, and lead to necrosis. This is also why
liquid embolic agents are no longer recommended.57 In
fact, dysphagia has been described to develop following
BAE in up to 18% of the cases,53,58 and the occurrence
of a bronchoesophageal fistula has also been reported.59
Equally, aortic and bronchial necrosis, although rare,
may also occur.60 However, the most commonly re-
ported complication following BAE is chest pain, which
has been described to occur in 24 to 91% of BAE
procedures.53,58,61
Coils may be employed when an aneurysm is
present or also when there is a need to protect a normal
vascular territory. Otherwise, the use of coils for bron-
chial embolization is not recommended as they may
produce an overly proximal occlusion, preventing the
performance of a repeat procedure should the hemopt-
ysis recur.57,62 Sometimes, the recurrence is due to the
presence of nonbronchial systemic feeder vessels that
must be searched for.54,57,62
LIVER
Trauma
Embolization is a useful technique in the therapeutic
management of patients with vascular injuries caused by
trauma, liver surgery, or percutaneous procedures.
Although such injuries are unusual, the presence of
hemobilia or hemoperitoneum resulting from pseudoa-
neurysm or laceration of a blood vessel may put the
patient critically at risk. Selective embolization of the
injury provides excellent results as far as hemostasis is
concerned (86%),63 although an associated morbidity of
58% has been described,64 which is basically connected
with bile leakage, liver abscesses, and/or necrosis. Such
lesions should therefore be treated on an individual
basis,65 with full awareness of the possible consequences
of a technique that is not risk-free.
Hepatocarcinoma
In patients with liver cancer that cannot be treated
surgically, but who have good liver function, emboliza-
tion only with particles, or associated with the
introduction of lipiodol and drugs (chemoemboliza-
tion), is a palliative therapeutic measure that is widely
accepted.66
Although controversy remains as to the criteria
for inclusion and the technique that should be used
(coaxial catheters, selection of particles, etc.), many series
have been published, and as a result, there is a large
amount of information available regarding possible com-
plications and steps to prevent them. The most common
complication after embolization, the cause of which is
still not properly understood, is the occurrence of fever,
pain in the right hypochondrium, and a rise in trans-
aminases. High temperature (< 38.5C) may occur be-
tween 41 and 74% of cases67,68 and seems to be related to
the presence of necrosis of the tumor and the healthy
tissue. Cytolysis (increase in transaminases), which is
present in up to 93% of cases, is related to damage to
healthy (noncancerous) hepatocytes. Contrary to what
was previously thought, it seems that the presence of
fever and cytolysis is not associated with a better re-
sponse or with an increase in survival.67
The possibility of acute hepatic decompensation
has been described in 20% of cases, although it is
irreversible in only 2%.68 The possible appearance of
hepatic insufficiency is related both with the dose of
cisplatin and the appropriate selection of patients. It
occurs more frequently in cases of advanced cirrhosis
with hyperbilirubinemia and abnormalities of the pro-
thrombin time68,69 and is practically absent in patients
with Child stages A and B.70
Hepatocarcinoma may manifest itself clinically in
the form of hemoperitoneum because of spontaneous
rupture; in such cases, embolization is a good therapeutic
option.71 Although this is infrequent, cases of tumor
rupture after arteriography have been described,72 after
lipiodol injection for tumor staging,73 and after thera-
peutic embolization.74,75
While Lipoidol is being introduced, in addition
to tumor uptake of the agent, it is common to observe
that small nontumor vascular branches that belong to
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portal vessels become opacified and are occluded.
This occlusion is temporary, but it causes an increase
in presinusoidal portal pressure, which can bring
about a pressure increase in the esophageal varices,76
possibly leading to rupture and gastrointestinal hem-
orrhage.
The biliary system is fed exclusively through the
hepatic artery, and as a result, arterial ischemia can result
in a biliary lesion, a well-known outcome in liver trans-
plant patients. Kim et al presented their experience with
807 patients with liver cancer treated by embolization;
they observed a 2% incidence of biliary complications.77
Among these, the most frequent was the presence of
subcapsular bilomas (71%), but there was also focal
stenosis of the common hepatic duct or of small intra-
hepatic radicals.77 It would seem that biliary complica-
tions are more frequent in patients with prior dilatation
of the bile ducts, small tumors, treatment that is repeated
within a short period of time, or when drugs are
associated with embolization.78 In exceptional cases, a
direct arteriobiliary connection has been described as a
result of biliary ischemia.79 Ischemia of the gallbladder is
worthy of a special mention. In nonselective emboliza-
tions performed from the right hepatic artery, the
embolizing agent can occlude the cystic branches,
and although complications due to this occlusion
are infrequent, cases of gallbladder necrosis have been
described.80
Hepatocarcinoma tends to produce infiltration of
the adjacent portal and hepatic veins. In fact, portal
infiltration is one of the angiographic features of hep-
atocarcinoma. Less frequently, early opacification of the
hepatic veins is observed, and there may even be high-
flow channels that pass undetected because they do not
become opacified. The use of small particles (< 100 mm)
may promote flow through the shunts mentioned toward
the heart, and therefore toward the pulmonary circula-
tion, resulting in massive pulmonary infarction with
disastrous consequences.81 It would seem that these
undesired embolizations are more frequent if the embo-
lization is performed through nonhepatic vessels that
vascularize the tumor (for example, the phrenic ar-
teries)82 (Fig. 2).
Hepatic Metastases
In symptomatic patients with hepatic metastases of
neuroendocrine tumors, embolization seems to be an
appropriate treatment and has an excellent response and
low morbidity.83,84 One complication that is feared in
these cases is the massive release of serotonin caused by
ischemia. Various methods of preventing this have been
described, such as infusion of a somatostatin (octeotride)
during the procedure. However, recent studies85 seem to
show that this treatment does not prevent serotonin
release during the procedure.
In patients with liver metastases of gastrointestinal
tumors, various chemotherapy protocols have been ap-
plied both intravenously and intra-arterially, with results
that are positive in both cases, though perhaps slightly
better in the case of intra-arterial administration. For
this reason, series have been described with repeated
insertion of catheters in the hepatic artery via femoral
catheterization or with insertion of a permanent catheter
fixed to a subcutaneous reservoir. In both cases, the most
frequent complications were hepatobiliary toxicity with
possible associated biliary lesion, occlusion of the hepatic
artery, infection of the catheter, or extrahepatic drug
infusion86 (Fig. 3). To prevent this last complication, all
extrahepatic vessels that originate from the hepatic artery
must be embolized (gastroduodenal, pancreatic, right
gastric, etc.).87 A special mention must be made of the
right gastric artery, the origin of which lies between the
proper hepatic and the left hepatic artery, although it
may also originate from a small segmentary artery. It is
important to detect and embolize it to prevent chemical
injuries of the stomach, which may occasionally be severe
(Fig. 4). There is a debate as to whether this artery ought
to be embolized from its hepatic origin86 or by entering
from the left gastric artery87; it appears that the second
possibility is safer, as unsuitable manipulations of the
hepatic arteries, which might result in spasm or dissec-
tion, are avoided.
Portal Vein Embolization
The complications of portal embolization can be div-
ided into several groups. First, the effect that ischemia
has on the hepatocytes is ‘‘apoptosis’’ and not ‘‘cell
necrosis,’’ and so the postembolization syndrome and
cytolysis are much less severe than in the case of arterial
embolization and may be absent altogether. Second,
there are the complications deriving from the trans-
hepatic puncture that are similar to those described in
Figure 2 Image taken after the embolization of a hepatocarci-
noma through the right inferior phrenic artery. Lipiodol (10 mL)
was used. Massive opacification of pulmonary vascularization
can be seen.
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Figure 3 Patient with hepatic metastasis from a colonic adenocarcinoma consulted us because of ictericia following intra-arterial
hepatic treatment performed by means of a reservoir implanted surgically in the proper hepatic artery. (A) The computed tomography
(CT) scan showed a liquid collection surrounding the portal branches. The suspected diagnosis was biliary necrosis due to ischemia and
chemotoxicity. (B) Image taken after the percutaneous implantation of a catheter in the cavity. The contrast surrounds all the right portal
branches and corresponds to a large periportal ‘‘biloma.’’ A catheter can be seen inserted surgically into the hepatic artery. (C)
Obstruction of the common hepatic artery with little collateral arterial vascularization to the liver. (D) Two weeks after the placement of
two external catheter drainages in both lobes, opacification of small interhepatic biliary branches and of the coledocus can be seen. (E)
After the punction of peripheral biliary branches, external-internal catheter drainages are introduced, through the ‘‘biloma,’’ connecting
with the coledocus and the duodenum. (F) After great clinical improvement, the CT taken 3 months later shows reduction of the size of
the intrahepatic collection and no biliary dilatation.
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other transparietohepatic techniques such as biliary
drainage; there are reports of pneumothorax, subcap-
sular hematoma, arterial pseudoaneurysm, or hemo-
bilia88 (Fig. 5). A third group of complications are
those caused by portal management itself. If the punc-
ture is insufficient or the manipulation excessive, or if
the embolization has affected large areas of the porta,
complete thrombosis of the porta may occur. This is a
severe complication that requires immediate direct
thrombolytic treatment. Therefore, there is a debate
as to whether the approach should be ipsilateral (enter-
ing the segmentary veins that are to be embolized) or
contralateral (through the veins that are to be left).
Some specialists consider that in view of the large
number of anatomical variants in the right portal
vein, the ipsilateral approach may involve technical
difficulties, with more manipulation and a greater risk
of thrombosis; others believe that the contralateral
approach puts an area at risk that should be left
untouched.88
The rise in portal pressure is moderate (gener-
ally 5 to 7 mm Hg), and this rise does not usually have
clinical consequences. However, in cirrhotic patients
with portal hypertension, this hemodynamic alteration
can result in rupture of gastroesophageal varices, and
in one case it was reported that it was necessary to
perform an emergency transjugular intrahepatic porto-
systemic shunt straight after portal embolization. One
complication that should be borne in mind is that the
tumor may remain untreated during the waiting time,
leading to the growth of nonembolized liver tissue,
and it may happen that resectable tumors have ceased
to be resectable by the time that surgery is finally
performed.89
SPLEEN
The present indications for performing partial occlu-
sion of the splenic flow and therefore a partial reduction
in its function have widened. The improvement of
hypersplenism is still a classic indication, being a
frequent complication in cirrhotic patients with portal
Figure 4 Patient with adenocarcinoma of the kidney who was treated by nephrectomy and who now shows hepatic metastasis. The
arteriography was taken to plan the treatment with embolization using yttrium radiospheres. (A) Arteriography from the common hepatic
artery, which, apart from the gastroduodenal artery, shows a thick right gastric artery. (B) To avoid infusion of particles into extrahepatic
areas, both arteries are embolized by means of coils.
Figure 5 CT performed 3 days after a presurgical portal embo-
lization. The portal punction was done, accidentally, through a
metastasic lesion placed in segment II, which had previously
received radiofrequency treatment. A subhepatic hematoma,
which did not need treatment, was observed. The nonembolized
liver grew correctly, in spite of the compression caused by the
hematoma.
132 SEMINARS IN INTERVENTIONAL RADIOLOGY/VOLUME 23, NUMBER 2 2006
hypertension. The embolization must preserve some
flow to the spleen to maintain partial splenic function.
In addition, if there is no flow in the splenic artery, the
inferior mesenteric vein may drain bacteria (physiolog-
ical mesenteric bacteremia) toward the devascularized
splenic parenchyma rather than the liver.90 This
phenomenon may lead to splenic abscesses, bacterial
peritonitis, and sepsis,91 although these severe com-
plications are infrequent (1 to 2%). Vascular necrosis
more commonly results in high temperature (94%) and
abdominal pain (82%). The occurrence of a left pleural
effusion (10%) or basal atelectasis (30%) is not un-
common, related to the reduced mobility of the dia-
phragm due to inflammation of the spleen.91 A further
serious but infrequent complication is portal throm-
bosis, which can occur in cases in which devasculari-
zation is complete, and the patient presents with portal
hypertension.
DIGESTIVE TRACT
The particular embolization technique used in patients
with gastrointestinal hemorrhage depends on various
factors. First, recognizing the differences between the
organs to be embolized is critical. For example, the
stomach has multiple afferent pedicles and an excellent
supply of collateral circulation. On the contrary, the
colon has abundant marginal vessels but of fine caliber
with little collateral supply. Second, cases that have
already undergone surgery require highly individual
assessment, as the ligature of pedicles means that many
vessels may be terminal, and the possibility of necrosis
resulting from ischemia exists. Third, attention should
be paid to the cause of hemorrhage because in some cases
it is enough to provoke hemostasis by occluding the
vessel temporarily, while in others, for example in the
case of neoplasm, careful embolization of all tumor
vessels is required (Fig. 6). For these three reasons, and
for others that are equally important, such as the state of
coagulation, the complications resulting from an embo-
lization may vary considerably.92
Stomach
In patients with no history of gastric surgery, emboliza-
tion of a bleeding ulcer is simple, and ischemic compli-
cations are rare. Special mention must be made of the
case of patients with diffuse hemorrhage that is not
controlled by endoscopic techniques. Occlusion of sev-
eral main gastric pedicles such as the left gastric and right
gastroepiploic arteries with gelatin sponge particles of 1
to 3 mm has been described, and is a common practice in
many hospitals.93 This ‘‘blind embolization’’ is thought
to reduce the blood supply temporarily, given that the
characteristics of the embolizing material and the rich
collateral arterial supply mean that the ischemia will be
of short duration. Cases of gastric ischemia have been
described when this technique is used, and so although it
is effective, it is not totally free of complications.94
Duodenum
The arterial vascularization of this area is an ‘‘arcade’’
that connects the anterior and posterior superior
branches, which depend on the gastroduodenal artery,
with the inferior ones, which depend on the superior
mesenteric artery. It is useful to know that this area can
also receive supply from accessory duodenal-pancreatic
branches, which may have their origin in possible aber-
rant right hepatic arteries (Fig. 7).
When attention is paid to the anatomy and an
appropriate technique is employed, the technical success
rate of embolization is very high (98%) and clinical
success may reach 80%.95 Therapeutic failures are more
frequent in cirrhotic patients and those with coagulation
disorders.95,96 This is even more likely when microcoils
alone are used in patients of this kind,95 and so on some
occasions it is necessary to use particles (gelfoam or
PVA) as well. Nonetheless, when particles, and above
all glues, are used, the possibility of ischemia is
greater,95,97 and the presence of duodenal stenosis
(40% of cases) has been reported in studies with suffi-
cient follow-up time.98
Small and Large Intestine
In the 1980s, embolization in this area was found to be
associated with unacceptably high rates of intestinal
ischemia and necrosis. For this reason, the use of vaso-
pressin infusions became widespread to encourage last-
ing vasoconstriction of the bleeding area. However, it
became apparent that this technique was also not free of
complications such as myocardial infarction, hyperten-
sion, and arrhythmia.99 As new materials for catheter-
ization and embolization were developed, it was found
that they provided greater vascular occlusion with regard
to clinical performance and that the complication rates
were lower.99,100 At present, the use of vasopressin and
similar agents is generally not advisable. Even if the area
is of high risk for embolization and temporary vaso-
constriction is required, it is preferable to achieve this
end by triggering vasospasm through intravascular ma-
nipulations of catheters and guide wires.101
In digestive hemorrhage of intestinal origin, the
current recommendation is to embolize, using a coaxial
technique, the vasa recta or the marginal arteries closest
to the bleeding point.102,103 If the occlusion is more
distal, the risk of necrosis rises, and if it is excessively
proximal, depending on the site, both ischemia and
rebleeding from collaterals may come about. If the
material is appropriately selected and the anatomy is
studied carefully, major complications will not occur and
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minor ones (abdominal pain) should happen in only 10%
of cases.103
KIDNEY
The indications for performing renal embolization have
been considerably reduced.104 In the 1980s, this techni-
que was performed preoperatively, and many series were
published concerning this indication.105 The rate of
major and minor complications was around 10%, the
most frequent being renal insufficiency and uninten-
tional embolization of nontarget areas.105 Infectious
complications were much less frequent, although some
retroperitoneal abscesses did occur.106 The use of etha-
nol as an embolic agent carries a greater possibility of
ischemia and necrosis than the use of coils, particles, or
even arterial occlusion balloons. The most frequently
described complication is colonic infarct caused by etha-
nol passing through the ventral area of the aorta to the
inferior mesenteric artery,107,108 but cases of skin ne-
crosis110 and testicular infarction have also been reported
(due to the aberrant origin of the left testicular artery).109
In the case of nonfunctioning kidneys, ablation
with ethanol is an effective alternative to nephrec-
tomy.111 When this technique has been used, postem-
bolization syndrome has been described as occurring in
Figure 6 Patient with pancreatic head carcinoma treated with radiotherapy and surgery. He presents severe digestive hemorrhage.
(A) Pseudoaneurysm in right hepatic artery. (B) Indirect portography from splenic artery. Portal thrombosis. (C) Selective catheterization
of pseudoaneurysm. (D) Rupture of pseudoaneurysm during the endocavitary manipulation of the coaxial catheter. (E) Arteriography
after the selective embolization of the lesion. The flow of the right hepatic artery, through arterial intrahepatic collateras, is preserved.
(F) Four months later the patient had another episode of digestive bleeding. In the arteriography a large pseudoaneurysm was observed,
placed proximal to the previous one. (G) Further rupture of the pseudoaneurysm during the catheterization. Major digestive bleeding.
(H) Arteriography after the complete occlusion of the vascular lesion and the hepatic artery distal and proximal to the rupture. The arterial
flow is partially maintained through collaterals of the lesser epiploon. The patient had no further episodes of bleeding or hepatic
ischemia.
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62% of cases.111 Other occasional complications include
renal abscess112 and emphysematous pyelonephritis.113
Cases of renal arteriovenous malformations are
increasingly being treated with embolization. In com-
parison with surgery, the therapeutic benefit is high, as
the parenchyma can be preserved, thereby maintaining
kidney function. Complications are rare: one case of
massive hematuria caused by an arteriopelvic fistula has
been reported after embolization with gelfoam and
microcoils,114 and another has been described resulting
from a fistula to the descending colon caused by coils
inside the lesion.115
Figure 7 Digestive hemorrhage after endoscopic papillotomy. The patient was treated by embolization of the gastroduodenal artery
with coils placed distally and proximally to the source of bleeding. A week later she had a new episode of hemorrhage. (A) Arteriography
from the proper hepatic artery shows good occlusion of the gastroduodenal artery. (B) Catheterization of the posteroinferior
pancreatoduodenal branch. Return of the bleeding. (C) Arteriography taken during the embolization of both arteries, persistent
hemorrhage. (D) Arteriography taken after the embolization of the pancreatoduodenal arch. Persistent hemorrhage. Coil in superior
mesenteric artery, which was extracted with a gooseneck. (E) Selective catheterization of an accessory pancreatoduodenal branch,
which comes from the origin of the aberrant right hepatic artery. (F) Arteriography taken after the embolization, with segments of
gelfoam, of the aberrant artery. The bleeding has stopped. The patient has had no further episodes of hemorrhage.
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As well as those secondary complications due to the
puncture (hematoma, pseudoaneurysm, arteriovenous
fı´stula, etc.), catheterization (dissection, perforation,
thrombosis, embolia, etc.), use of coaxial systems
(intraluminal thrombosis, embolus, etc.), and use of
microcatheters and microguides (arterial perforation,
dissection, etc.) and those specifically due to the use of
different embolization materials (coils, particles, poly-
merizing materials, etc.), there are other complications
specific to the arterial system being embolized.
Uterine Myoma
According to Spies et al,116 in the embolization of
uterine myomas the most frequent complications are:
allergic reactions (4%), fever (2%), hemorrhage (0.75%),
and vaginal bleeding (0.5%). Other complications in-
clude, which appears in almost all cases in the first
12 hours and frequently persists for several days (it is
usually controlled by the use of analgesics such as para-
cetamol), and infection, which may become pyometra
and be the cause of a hysterectomy. Some extremely rare
complications have been described, such as septicemia
and thrombophlebitis of the pelvic veins, sometimes
associated with a pulmonary embolism that can even
result in death. This type of complication is more
common when the myomas are large.117–119 Other stud-
ies have reported complications such as uterine prolapse
and loss of ovarian function, appearing as transitory or
permanent amenorrhea. This latter complication is more
frequent in women over 50120 (Fig. 8). There are also
descriptions of secondary amenorrhea associated with
endometrial atrophy despite normal ovarian function.121
Similar complications are possible in the embolization of
the uterine arteries to control postpartum hemorrhage,
hemorrhage associated with spontaneous or induced
abortion,122–124 or hemorrhage associated with gesta-
tional trophoblastic disease, sometimes treated by embo-
lization of the internal iliac arteries.125 To avoid the
complications described in this section it is preferable to
selectively embolize the uterine arteries.
Embolization of the hypogastric arteries is fre-
quently used as a therapeutic measure in cases of uncon-
trollable hematuria of vesicular or prostatic origin,
arterial lacerations, and multifocal pelvic trauma. In
these cases, unilateral or bilateral embolization of the
hypogastric arteries is typically performed. For example,
although aneurysms that affect the common or internal
iliac arteries are treated by implanting percutaneous
prostheses, aneurysms associated with retrograde flow
from an aortobifemoral bypass are often treated by
embolization of the hypogastric arteries. In all these
cases, the most frequent complications are fever, gluteus
ischemia with or without claudication, infection, and
vascular perforation.126,127 There are also descriptions of
necrosis of the skin, sexual dysfunction such as vaginal
dryness and impotence, and muscular atrophy, although
these problems may be due to the underlying disease and
have no relationship with the embolization.128,129 When
Figure 8 Embolization of a uterine myoma after bilateral catheterization (A,B) of the uterine arteries. Both arteries can be seen; 500 to
700 microparticles were used. After embolization, the patient had permanent amenorrhea.
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the origins of the superior and inferior mesenteric
arteries are abnormal, intestinal vascularization may
depend on the hypogastric arteries. In such situations,
intestinal vascularization may depend on the hypogastric
arteries, and the embolization of these arteries may result
in intestinal ischemia. Distal internal iliac artery embo-
lization may also result in colon ischemia. As a result, in
these situations embolization of the hypogastric arteries
must be as proximal as possible.130 Finally, when treating
aneurysms of the common and internal iliac arteries,
careful technique is necessary to prevent rupture.
Other Pelvic Embolizations
Neurological damage (paraparesis, neuropathy) may re-
sult from several pelvic embolization procedures, includ-
ing the treatment of vascular malformations with
bucrylate or the treatment of trauma to the sacral plexus
or pelvic ring using particles that are too small. Necrosis
of the skin, bladder,131 or other intra-abdominal organs
has also been described, and even ischemia of the spinal
medulla may occur, most commonly when embolization
of the arteries of the lumbar, sacral, or vertebral areas is
necessary.
In the treatment of priapism by means of embo-
lization, impotence is described as a secondary compli-
cation. Occlusion of the arteries of the pudenda should
be avoided132 whenever possible during pelvic emboliza-
tion to avoid this complication.
Finally, embolization plays an important role in
the treatment of retroperitoneal hematomas to achieve
the hemodynamic stability of the patient. Complications
vary depending on the vascular distribution that must be
embolized, but in every case, the most feared complica-
tion is infection of the hematoma. Therefore aseptic
technique and correct antibiotic prophylaxis is of ex-
treme importance.
VASCULAR MALFORMATIONS
Vascular malformations may be classified according to
flow characteristics, including low flow (capillary, lym-
phatic, and venous) and high flow (arteriovenous).133,134
Low-flow malformations are mainly treated by sclero-
sant injection, and high-flow malformations are treated
by embolization.135–138
Among the sclerosant agents employed in the
treatment of venous malformations, the most commonly
used are absolute ethanol139,140 and the detergent scle-
rosants, including sodium tetradecyl sulfate, polydoca-
nol, sodium morrhuate, and ethanolamine.141–145 All
have in common the ability to produce endothelial
damage, which ultimately results in thrombosis and
fibrosis.
Absolute ethanol is the most potent of the scle-
rosant drugs and hence the most difficult to use, poten-
tially causing serious complications and side effects. The
maximum dose of 1 mL/kg weight should not be
exceeded in any single session because of its toxic
effect.135 Pain and substantial swelling should be con-
sidered expected side effects rather than complica-
tions.146,147 The use of systemic steroids and analgesics
may minimize these side effects. Depending on the
location of the lesion, the swelling may obstruct vital
structures such as the airway or the alimentary canal135
and thereby lead to additional problems. Administration
should be performed under general anesthesia with close
monitoring, even with a Swan Ganz catheter in the
pulmonary artery as pulmonary vasospasm, cardiac ar-
rhythmias, and cardiopulmonary collapse are known
complications following its use.146,148 Skin necrosis,
blistering, and even more serious ischemic damage may
occur, particularly when inadvertently injected into a
nontarget artery with resultant embolization of normal
capillary beds.135,146,149 Peripheral nerve deficits may
develop not only because of ischemic damage to the
vasa nervorum but also due to sustained compression by
the swelling.138
The detergent sclerosant drugs rarely cause ad-
verse effects, although there has been at least one report
of a reversible cardiac arrest following the use of poly-
docanol.150 Allergic reactions have also been de-
scribed.151 When used as a foam or microfoam, it is
possible that small air emboli may reach the pulmonary
circulation but usually without any clinical significance
in our personal experience. Hemoglobinuria may de-
velop as a consequence of the hemolysis that follows any
sclerosant injection; therefore, good hydration and mon-
itoring of urine output and alkalinization are strongly
recommended.135
Among the sclerosant agents employed in the
treatment of lymphatic malformations, some (e.g.,
OK-432) have virtually no side effects and others (e.g.,
bleomycin), when used in large doses, may produce toxic
effects such as pulmonary fibrosis and alopecia.152 Ethi-
bloc virtually always causes the skin to split as it is
extruded and this should not be considered a complica-
tion unless infection develops. Prophylactic antibiotics
are advised when treating lymphatic malformations as
they tend to become infected quite frequently, even
spontaneously.135
What has been said so far in connection with
the use of absolute ethanol in low-flow malforma-
tions applies as well for arteriovenous malformations.
Embolization with particles or liquid agents may be
performed, most commonly preoperatively with the
intention of reducing the size of the nidus and
minimizing the amount of blood loss during sur-
gery.153 This practice is particularly helpful for those
malformations that are not situated in the limbs
and therefore cannot be excised with the aid of
tourniquets.
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